UNSW Sydney leads the NSW RNA Production and Research Network (NSW-RPRN), a network funded by the NSW Health Office of Health & Medical Research to: 

  • Seed the RNA therapeutics R&D ecosystem in NSW and ACT 
  • Train the future workforce for the RNA therapeutics industry

NSW Health logo

NSW-RPRN Member Organisations

The NSW-RPRN includes several universities and medical research institutions and has built relationships with a number of support organizations located in NSW and the ACT that provide critical infrastructure and expertise for the development of RNA-based therapeutics: 

  • UNSW
  • UTS
  • Macquarie University
  • University of Sydney
  • ANU 
  • Children’s Medical Research Institute
  • Kirby Institute
  • Westmead Institute of Medical Research
  • Woolcock Institute of Medical Research
  • Children’s Cancer Institute
  • Royal Prince Alfred Hospital
  • Ramaciotti Centre for Genomics
  • UNSW Recombinant Products Facility
  • Centenary Institute
  • Australian Proteome Analysis Facility
  • The ANU Centre for Therapeutic Discovery
  • Cell & Molecular Therapies
  • Microbial Genomics Reference Laboratory
  • Sydney Infectious Diseases Institute 
NSW-RPRN Governance
Management Committee

Pall Thordarson – Coordinator, UNSW Sydney 

Scott Cohen – Children’s Medical Research Institute, Westmead 

Daniela Traini – Woolcock Institute 

Richard Payne – University of Sydney 

Christopher Marquis – UNSW Sydney 

Anthony Kelleher – Kirby Institute 

Maria Kavallaris – Children’s Cancer Institute 

External Expert Advisory Committee

Scott McNeil – University of Basel 

Julie Suman – Next Breath 

Archa Fox – University of Western Australia 

Gary Philips – Pharmaxis 

Phil Kearney -- Merck 

John Skerritt – TGA Australia (observer) 

Management and Administration

UNSW is the lead institution and is the base for management and governance of the NSW-RPRN  including activities such as reporting and outreach.

Key Contacts: Joshua Peterson, Catherine McDonald, Marjorie Fox-Owens